According to Mirati Therapeutics's latest financial reports the company's current revenue (TTM) is $38.19 M. In 2022 the company made a revenue of $12.43 M a decrease over the years 2021 revenue that were of $72.09 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $38.19 M | 207.1% |
2022 | $12.43 M | -82.75% |
2021 | $72.09 M | 438.04% |
2020 | $13.39 M | 301.77% |
2019 | $3.33 M | -74.2% |
2018 | $12.92 M | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A | -100% |
2012 | -$0.01 M | -100% |
2011 | $3.19 M | 34.24% |
2010 | $2.38 M | -8.89% |
2009 | $2.61 M | -89.33% |
2008 | $24.51 M | 64.43% |
2007 | $14.9 M | 8.8% |
2006 | $13.7 M | 144.42% |
2005 | $5.6 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
TravelCenters of America TA | $10.78 B | 28,144.71% | ๐บ๐ธ USA |
Nymox Pharmaceutical NYMX | N/A | N/A | Bahamas |